| Keenan Smith, PMHNP-BC | |
|
2105 112th Ave Ne Ste 201, Bellevue, WA 98004-2945 | |
| (425) 968-5948 | |
| Not Available |
| Full Name | Keenan Smith |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 2105 112th Ave Ne Ste 201, Bellevue, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003519372 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Keenan Smith, PMHNP-BC Po Box 1097, Birmingham, MI 48012-1097 Ph: (248) 838-9586 | Keenan Smith, PMHNP-BC 2105 112th Ave Ne Ste 201, Bellevue, WA 98004-2945 Ph: (425) 968-5948 |
News Archive
Pathway Genomics Inc., a U.S. based genetic testing company, announced the immediate availability of its personal Genetic Health Report. This customized and innovative personal genetic health report contains information on more than 70 health conditions, including pharmacogenetics (prescription medication response), propensity for complex disease, and carrier status (pre-pregnancy health).
A paper published in the current issue of Psychotherapy and Psychosomatics provides new findings on the role of psychotherapy in regulating serotonin receptors.
People who take regular exercise into old age are better able to cope with everyday activities and for longer, retain their independence and are not reliant on outside help, thereby saving themselves and society the cost of care and support.
How can defective gene activity, which can ultimately lead to cancer, be avoided? Researchers at the University of Zurich have now identified a mechanism how cells pass on the regulation of genetic information through epigenetic modifications. These insights open the door to new approaches for future cancer treatments.
BioTrends Research Group released topline findings from LaunchTrends®: ACTEMRA, Wave 1 today, highlighting the market uptake of the product at one month post launch. Actemra (tocilizumab), marketed by Roche-Genentech, is a new IL-6 inhibitor with monthly dosing by IV infusion. The study results are based on an on-line survey completed by 77 rheumatologists in late February.
› Verified 4 days ago
Ms. Jessica Swenson, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1231 116th Ave Ne, Suite 950, Bellevue, WA 98004 Phone: 425-454-3366 Fax: 425-460-5954 | |
Mrs. Kara Harrington Brennan, MSN, ARNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 11522 Ne 20th St, Bellevue, WA 98004 Phone: 425-462-2531 Fax: 425-454-6176 | |
Dr. Ambera Dedic, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1231 116th Ave Ne Ste 400, Bellevue, WA 98004 Phone: 425-289-3199 | |
Leslie Elaine Smith, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1600 116th Ave Ne, Suite #102, Bellevue, WA 98004 Phone: 425-454-5311 Fax: 425-454-8188 | |
Hana K Ryan, AGPCNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 11695 Ne 4th St, Bellevue, WA 98004 Phone: 425-637-1855 Fax: 425-344-7970 | |
Thomas Chan, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 15585 Ne 24th St, Bellevue, WA 98007 Phone: 888-227-3312 |